Northwestern University There’s a budding scientific literature supporting the idea that so-called messenger RNA vaccines, in prompting a robust immune response inside the body, can help cancer patients. The COVID-19 vaccines could be doing a lot more than just warding off viral infection: they may be teaching our immune systems how to fight cancer more effectively.
There’s a growing body of scientific literature supporting the idea that so-called messenger RNA (mRNA) vaccines, by prompting a robust immune response within the body, can help cancer patients. And Northeastern University vaccine experts say the pandemic-era tech holds real promise as a tool to combat one of the world’s deadliest diseases.
“There is ample evidence showing how mRNA technology can transform how we prevent and treat diseases, including these cross benefits that we’re starting to see in cancer patients,” says Mansoor Amiji, university distinguished professor of pharmaceutical sciences and chemical engineering.